Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital
Open Access
- 20 October 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 56 (6) , 1107-1110
- https://doi.org/10.1093/jac/dki370
Abstract
Objectives: To characterize the β-lactamase genes of the expanded-spectrum cephalosporin-resistant Escherichia coli isolates recovered in a Spanish hospital during the March 2002–March 2003 period. Methods: Thirty-four of the 1700 E. coli isolates recovered from unrelated patients in a Spanish hospital showed expanded-spectrum cephalosporin resistance. The presence of genes encoding TEM, SHV, CTX-M, CMY-2-type or FOX β-lactamases as well as the existence of mutations in the regulatory region of the chromosomal ampC gene were studied by PCR and sequencing in these 34 E. coli isolates. Results: The following extended-spectrum β-lactamases (ESBLs) or plasmidic class C β-lactamase genes were detected (number of isolates): blaCTX-M-14 (14), blaCTX-M-9 (4), blaCTX-M-32 (1), blaTEM-52 (2), blaSHV-12 (3) and blaCMY-2 (2). The remaining eight isolates showed a mutation in the promoter/attenuator region of the ampC chromosomal gene at position −42, in combination with mutations at positions −18, −1 and +58. The blaTEM-1 gene was also detected in 12 of the ESBL-producing isolates, in both CMY-2-producing isolates and in four of the eight isolates that showed a mutation at position −42 of the ampC promoter. Other mutations in the promoter/attenuator region were detected in association with ESBL or CMY-2 genes, such as the combination −18, −1 and +58, −28 and +58, or +22, +26, +27 and +32. No clonal relationship was found among the CTX-M-producing E. coli isolates by PFGE with XbaI enzyme. Conclusions: Approximately 1.5% of the E. coli isolates of our hospital harboured ESBL genes, those of the CTX-M-9 group being the most common ones.Keywords
This publication has 10 references indexed in Scilit:
- Monitoring and Characterization of Extended-Spectrum β-Lactamases in Escherichia coli Strains from Healthy and Sick Animals in Spain in 2003Antimicrobial Agents and Chemotherapy, 2005
- Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian HospitalsAntimicrobial Agents and Chemotherapy, 2005
- Dramatic Increase in Prevalence of Fecal Carriage of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae during Nonoutbreak Situations in SpainJournal of Clinical Microbiology, 2004
- High-Level Resistance to Ceftazidime Conferred by a Novel Enzyme, CTX-M-32, Derived from CTX-M-1 through a Single Asp240-Gly SubstitutionAntimicrobial Agents and Chemotherapy, 2004
- Diversity of genetic environment ofblaCTX-MgenesFEMS Microbiology Letters, 2004
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Identification and Broad Dissemination of the CTX-M-14 β-Lactamase in Different Escherichia coli Strains in the Northwest Area of SpainJournal of Clinical Microbiology, 2002
- Plasmid-Determined AmpC-Type β-LactamasesAntimicrobial Agents and Chemotherapy, 2002
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpCJournal of Antimicrobial Chemotherapy, 2000